| Copper | Approved Investigational | CD3EAP | 10849 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CD3EAP mRNA | 19q13.32 | |
| Copper | Approved Investigational | CD46 | 4179 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of CD46 mRNA | 1q32.2 | |
| Copper | Approved Investigational | CD47 | 961 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of CD47 mRNA | 3q13.12 | |
| Copper | Approved Investigational | CD47 | 961 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CD47 mRNA | 3q13.12 | |
| Copper | Approved Investigational | CD58 | 965 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CD58 mRNA | 1p13.1 | |
| Copper | Approved Investigational | CD9 | 928 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of CD9 mRNA | 12p13.31 | |
| Copper | Approved Investigational | CDC25A | 993 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CDC25A mRNA | 3p21.31 | |
| Copper | Approved Investigational | CDC42EP5 | 148170 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of CDC42EP5 mRNA | 19q13.42 | |
| Copper | Approved Investigational | CDC45 | 8318 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CDC45 mRNA | 22q11.21 | |
| Copper | Approved Investigational | CDC7 | 8317 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CDC7 mRNA | 1p22.1 | |
| Copper | Approved Investigational | CDCA3 | 83461 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CDCA3 mRNA | 12p13.31 | |
| Copper | Approved Investigational | CDCA7 | 83879 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CDCA7 mRNA | 2q31.1 | |
| Copper | Approved Investigational | CDCA7L | 55536 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CDCA7L mRNA | 7p15.3 | |
| Copper | Approved Investigational | CDH11 | 1009 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of CDH11 mRNA | 16q21 | |
| Copper | Approved Investigational | CDH12 | 1010 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CDH12 mRNA | 5p14.3 | |
| Copper | Approved Investigational | CDH2 | 1000 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of CDH2 mRNA | 18q12.1 | |
| Copper | Approved Investigational | CDH3 | 1001 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CDH3 mRNA | 16q22.1 | |
| Copper | Approved Investigational | CDK1 | 983 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CDK1 mRNA | 10q21.2 | |
| Copper | Approved Investigational | CDK19 | 23097 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CDK19 mRNA | 6q21 | |
| Copper | Approved Investigational | CDK2 | 1017 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CDK2 mRNA | 12q13.2 | |
| Copper | Approved Investigational | CDK5R1 | 8851 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of CDK5R1 mRNA | 17q11.2 | |
| Copper | Approved Investigational | CDK5RAP3 | 80279 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of CDK5RAP3 mRNA | 17q21.32 | |
| Copper | Approved Investigational | CDKN1A | 1026 |
upregulated | [Copper results in increased activity of TP53 protein] which results in increased expression of CDKN1A mRNA | 6p21.2 | |
| Copper | Approved Investigational | CDKN1A | 1026 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CDKN1A mRNA | 6p21.2 | |
| Copper | Approved Investigational | CDKN1C | 1028 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of CDKN1C mRNA | 11p15.4 | |